[DOI] [PMC free article] [PubMed] [Google Scholar] 214.Smith EP, An Z, Wagner C, Lewis AG, Cohen EB, Li B, Mahbod P, Sandoval D, Perez-Tilve D, Tamarina N, Philipson LH, Stoffers DA, Seeley RJ, DAlessio DA
Persistent pain, swelling, reduced range of motion, warmth, or redness can indicate post-injection inflammation, infection, or an improper injection technique that requires medical evaluation
All licensed GLP-1 receptor agonists are administered either as subcutaneous injections or, in limited cases, as oral tablets (such as oral semaglutide, marketed as Rybelsus)
PMID: 36789109
KellerJBassottiGClarkeJDinningPFoxMGroverMet al
On the other hand, Liraglutide, which requires daily injections, may be more suited to patients who need more immediate effects due to its shorter half-life but are comfortable with daily injections